Market capitalization | CAD1.29b |
Enterprise Value | CAD1.70b |
P/E (TTM) P/E ratio | 17.02 |
EV/FCF (TTM) EV/FCF | 18.13 |
EV/Sales (TTM) EV/Sales | 1.77 |
P/S ratio (TTM) P/S ratio | 1.35 |
P/B ratio (TTM) P/B ratio | 1.53 |
Revenue growth (TTM) Revenue growth | 36.56% |
Revenue (TTM) Revenue | CAD957.69m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
15 Analysts have issued a WELL Health Technologies forecast:
15 Analysts have issued a WELL Health Technologies forecast:
Sep '24 |
+/-
%
|
||
Revenue | 958 958 |
37%
37%
|
|
Gross Profit | 355 355 |
21%
21%
|
|
EBITDA | 125 125 |
39%
39%
|
EBIT (Operating Income) EBIT | 57 57 |
80%
80%
|
Net Profit | 73 73 |
1,134%
1,134%
|
In millions CAD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. It operates through Clinical, and Electronic Medical Records (EMR) segments. The Clinical segment operates a network of clinics across Canada. The EMR segment provides Open Source Clinical Application Resource (OSCAR) EMR software and services to clinics. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.
Head office | Canada |
CEO | Hamed Shahbazi |
Founded | 2010 |
Website | www.well.company |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.